FIELD: biotechnology.
SUBSTANCE: method for the production of natural killer cells is disclosed. The method includes isolation of peripheral blood mononuclear cells (hereinafter – PBMC) from a blood sample; isolation of at least one of CD56+ cells and/or CD3-/CD56+ cells from PBMC; and co-cultivation of at least one of CD56+ cells and/or CD3-/CD56+ cells with a combination of feeding cells in the presence of at least two cytokines, characterized in that the combination of feeding cells contains irradiated Jurkat cells and irradiated cells of an Epstein-Barr virus-transformed lymphocyte continuous line (EBV-LCL), and at least two cytokines are IL-2 and IL-21. A composition for administration to a patient in need for treatment with NK cells is also disclosed, including: NK cells multiplied in a culture in accordance with the specified method; and a pharmaceutically acceptable carrier, characterized in that multiplied NK cells have a higher level of cytotoxicity and/or anticancer activity. In addition, a method for the reproduction of NK cells in a culture is described, including: isolation of peripheral blood mononuclear cells (PBMC) from a blood sample; isolation of at least one of CD56+ cells and/or CD3-/CD56+ cells from PBMC; and co-cultivation of at least one of CD56+ cells and/or CD3-/CD56+ cells with a combination of feeding cells in the presence of at least two cytokines, characterized in that the combination of feeding cells contains irradiated Jurkat cells and irradiated cells of an Epstein-Barr virus-transformed lymphocyte continuous line (EBV-LCL), and at least two cytokines are IL-2 and IL-21, and at the same time, feeding cells and cytokines are added at certain intervals throughout the reproduction in a culture.
EFFECT: invention makes it possible to obtain natural killer cells of high purity.
38 cl, 9 tbl, 21 ex, 14 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR LONG-TERM CULTIVATION AND EXPANSION OF NK CELLS WITH HIGH VIABILITY AND FUNCTIONAL ACTIVITY | 2021 |
|
RU2794770C1 |
CENTRAL MEMORY T-CELLS OF AGAINST THIRD PARTY, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION IN TRANSPLANTATION AND DISEASES TREATMENT | 2012 |
|
RU2636503C2 |
NATURAL KILLER CELLS RESISTANT TO TRANSFORMING GROWTH FACTOR BETA | 2019 |
|
RU2830178C2 |
METHODS OF EXPANSION OF ANTIGEN-SPECIFIC CAR-T-CELLS, COMPOSITIONS AND THEIR USE | 2019 |
|
RU2800920C2 |
PARTICLES PM21 FOR IMPROVEMENT OF HOMING OF NK-CELLS IN BONE MARROW | 2018 |
|
RU2777993C2 |
BI- OR MULTISPECIFIC POLYPEPTIDES BINDING IMMUNE EFFECTOR CELL SURFACE ANTIGENS AND HBV ANTIGENS FOR TREATMENT OF BV INFECTIONS AND ASSOCIATED CONDITIONS | 2014 |
|
RU2671089C2 |
IMPROVED METHODS FOR PRODUCING ADOPTIVE CELL THERAPY AGENTS | 2015 |
|
RU2741899C2 |
METHOD FOR EXPANSION OF HUMAN NK CELLS USING FEEDER CELLS | 2021 |
|
RU2781777C2 |
VETO-CELLS OBTAINED FROM MEMORY T-CELLS | 2017 |
|
RU2779844C2 |
METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE | 2019 |
|
RU2814083C2 |
Authors
Dates
2022-10-04—Published
2019-01-31—Filed